Welcome to the Knowledge Transfer Centre
The KTC works to increase the wider use and positive impact of the University's research activities. KTC staff have a deep understanding of the expertise and knowledge generation within the University, and develop networks and contacts externally with business.
KTC Director, Dr Ewan Chirnside, features in the latest Spinouts UK quarterly journal:
“We have ‘pivoted’ our business approach to enterprise, spinouts and start-ups – we now support a strategy of ‘patient IP’ (akin to patient capital), and establish and support soft start businesses around opportunities within the university to test the commercial viability and/or develop technology which we are looking to exploit”
Read the full article on Spinouts UK.
The long history of university-business collaboration
The KTC's Business Innovation Manager, Dr Sophie Mullins, guest blogging for Interface.
From the printing press in fifteenth century Paris, to Silicon Valley and beyond.
If you're thinking of working with a university or want to learn about the history of university-business collaboration then this blog is for you.
Navigating university KE for businesses infographic (PDF, 69 KB).
Discovery Prize winners
Congratulations to Professor Stephen Gillespie's Infection Group who were awarded the Discovery Prize for their contribution to the fight against antimicrobial resistance.
Orbital Diagnostic's SLIC device tests bacteria for resistance to antibiotics, helping patients get an effective treatment and preventing the exposure of bacteria to antibiotics unnecessarily. The prize will help the team continue to develop a point-of-care device to challenge for the prestigious Longitude Prize.
Highlights from 2015-2016
Prize-winning university spin-out companies
- Ripptide won the Innovation Award at the 2015 Scottish Life Science Awards (held in 2016)
- Xelect won the 2016 Fife Business Award for “Most Enterprising Company”
- MOFgen won the 2016 Royal Society of Chemistry Emerging Technologies competition
- Beyond Medics won the 2016 Converge Challenge Kickstart competition
Four new companies
- Beyond Medics – remote sensing of key clinical signs
- Ripptide – development of novel cyclic peptides
- Pneumagen – development of antiviral and antibacterial therapies
- St Andrews Lean Consulting – provision of efficiency & process improvement advice
Crowdfunding and investment
Following Ambicare Health’s successful 2015 crowdfunding of £530k, in 2016 Xelect Ltd raised expansion funding from the St Andrews-based EOS angel network and Genuswave from its private backers. Ripptide, MOFgen & Pneumagen also pitched for investment in 2016 and two of these companies are on track to receive investment funding in AY 2016-17.